An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.
A Closer Look at FDA warning Avelumab Merkel cell carcinoma
In-depth context and analysis on this topic for researchers and advocates.
Reference: National Institutes of Health (NIH)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: MedlinePlus — Trusted Health Information
Authoritative source for clinical, regulatory, and public-health background reading.